CD6 and prostate carcinoma: Co-culture experiments using breast, lung, and prostate cancer cell lines showed substantial enhancement of cancer cell death in the presence of human lymphocytes and UMCD6, an anti-CD6 monoclonal antibody that rapidly caps and internalizes CD6.